In May, real-estate investing start-up Cadre found itself in the limelight when The Wall Street Journal reported that Jared Kushner, President Donald Trump's son-in-law, had failed to disclose his investment in the three-year-old company when he became a senior adviser to Trump. Jared and his younger brother, Josh, are both listed as the company’s co-founders, along with Ryan Williams, who met Josh Kushner at Harvard. Before Trump’s inauguration, Jared Kushner stepped down from Cadre’s board and sold some of his stake in the company, Bloomberg reports.

Now, the company has raised $65 million in funding, valuing Cadre at $800 million. The biggest firm to invest in the new round of funding is Silicon Valley heavyweight Andreessen Horowitz, which joins a number of institutional investors, including Vinod Khosla, David Yu, George Soros, and Trump adviser Peter Thiel in backing the real-estate tech start-up. The new influx of cash also seems to be an opportunity to refocus the attention around Cadre away from it being the company Kushner co-founded. (Williams told Bloomberg that Kushner had been “a really important adviser” who now “has no operational control, governance, or say in the company.”)

Cadre is just one Kushner-connected start-up in the tech world. Before he divested from his assets, Kushner had a $30 million stake in Thrive, his brother’s venture-capital firm, which invests in companies that include Slack, Glossier, Juicero, and, of course, Cadre. Cadre, which lets accredited investors with a net worth of $1 million pool their money to buy stakes in buildings, still counts Jared Kushner among those who hold a stake in the company, though Williams says it’s Josh who is more involved now.

While Josh has sought to depoliticize his businesses, his older brother remains an influence. Besides their divergent personal politics, Jared Kushner is also a crucial part of the Trump administration team that is seeking to repeal and replace Obamacare, whose exchanges underpin Josh’s health-insurance company, Oscar. As recently as last fall, the start-up was bleeding money, even before his brother went to work in Washington to help dismantle the Affordable Care Act.